Necati Harmankaya - Publications

Antioxidant-mediated control of degradation and drug release from surface-eroding poly(ethylene carbonate).

Journal: Acta biomaterialia

Published: February 20, 2020

Efflux Inhibitor Bicalutamide Increases Oral Bioavailability of the Poorly Soluble Efflux Substrate Docetaxel in Co-Amorphous Anti-Cancer Combination Therapy.

Journal: Molecules (Basel, Switzerland)

Published: November 26, 2018

Exploring the potential for rosacea therapeutics of siRNA dispersion in topical emulsions.

Journal: Experimental dermatology

Published: July 11, 2018

Anti-tuberculosis drug combination for controlled oral delivery using 3D printed compartmental dosage forms: From drug product design to in vivo testing.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: August 10, 2017

Molecular weight-dependent degradation and drug release of surface-eroding poly(ethylene carbonate).

Journal: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V

Published: September 30, 2016

Stem cell homing using local delivery of plerixafor and stromal derived growth factor-1alpha for improved bone regeneration around Ti-implants.

Journal: Journal of biomedical materials research. Part A

Published: March 11, 2016

Ex vivo alendronate localization at the mesoporous titania implant/bone interface.

Journal: Journal of materials science. Materials in medicine

Published: May 21, 2014

Raloxifene and alendronate containing thin mesoporous titanium oxide films improve implant fixation to bone.

Journal: Acta biomaterialia

Published: October 24, 2012

Healing of complement activating Ti implants compared with non-activating Ti in rat tibia.

Journal: Acta biomaterialia

Published: February 27, 2012